mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |